Predict drug sensitivity

Estimate cancer-cell responses from RNA profiles.

Choose a public cell-line profile or use your own RNA values. Inspect supported compounds, dose ranges, uncertainty and performance on cell lines excluded from training.

The endpoint is laboratory cancer-cell viability, not patient response or drug approval.